Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

Foodborne diseases (FBDs) remain a persistent global challenge and recent research efforts suggest that lactic acid bacteria (LAB) strains can contribute towards their prevention and treatment. This study investigates the genetic properties of Streptococcus thermophilus KLDS 3.1003 as a potential probiotic and health-promoting LAB strain as well as its in vitro and in vivo activities against two foodborne pathogens. In vitro, its antimicrobial activities and tolerance levels in simulated bile salts and acids were determined. The cytotoxic effects of the LAB strain in RAW264.7 cells were also evaluated. For in vivo evaluation, 24 BALB/c mice were orally administered control and trial diets for 14 days. Genomic analyses of this strain's bacteriocin configuration, stress response system and multidrug resistance genes were annotated to validate in vitro and in vivo results. In vitro antimicrobial results show that the cells and CFS of S. thermophilus KLDS 3.1003 could inhibit both pathogens with the former being more effective (P < 0.05). In addition, its cell-free supernatant (CFS) could inhibit the growth of both pathogens, with catalase treatment having the highest effect against it. More so, after 3 h of incubation, survivability levels of S. thermophilus KLDS 3.1003 were significantly high (P < 0.05). LPS-induced RAW264.7 cell activities were also significantly reduced by 108-109 CFU mL-1 of S. thermophilus KLDS. In vivo, significant weight losses were inhibited in the TSTEC group compared to the TSTSA group (P < 0.05). Moreover, pathogen-disrupted blood biochemical parameters like HDL, LDL, TP, TG, AST, ALT and some minerals were restored in the respective prevention groups (TSTEC and TSTSA). Genomic analyses showed that S. thermophilus KLDS 3.1003 has bacteriocin-coding peptides, which accounts for its antimicrobial abilities in vitro and in vivo. S. thermophilus KLDS 3.1003 is also endowed with intact genes for acid tolerance, salt-resistance, cold and heat shock responses and antioxidant activities, which are required to promote activities against the selected foodborne pathogens. This study showed that S. thermophilus KLDS 3.1003 has the genomic capacity to inhibit foodborne pathogens' growth in vitro and in vivo, thus qualifying it as a potential probiotic, antimicrobial and bio-therapeutic candidate.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Streptococcus thermophilusInhibited Weight Loss in MiceBeneficial
Large
Streptococcus thermophilusNormalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilusReduced Inflammatory Cell ActivityBeneficial
Large
Streptococcus thermophilusReduced Pathogen GrowthBeneficial
Large
Streptococcus thermophilus MAK34S24TImproved Serum BiochemistryBeneficial
Large
Streptococcus thermophilus MAK34S24TPrevented Significant Weight LossBeneficial
Large
Streptococcus thermophilus MAK34S24TReduced Inflammation in RAW264.7 CellsBeneficial
Large
Streptococcus thermophilus MAK34S24TReduced Pathogen GrowthBeneficial
Large
Streptococcus thermophilus PXN 66Enhanced Antimicrobial ActivityBeneficial
Large
Streptococcus thermophilus PXN 66Enhanced Stress ResistanceBeneficial
Large
Streptococcus thermophilus PXN 66Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus PXN 66Prevention of Weight LossBeneficial
Large
Streptococcus thermophilus PXN 66Reduced Inflammation in RAW264.7 CellsBeneficial
Large
Streptococcus thermophilus PXN 66Reduced Pathogen ActivityBeneficial
Large
Streptococcus thermophilus SEBioticImproved Biochemical ParametersBeneficial
Large
Streptococcus thermophilus SEBioticReduced CytotoxicityBeneficial
Large
Streptococcus thermophilus SEBioticReduced Pathogen GrowthBeneficial
Large
Streptococcus thermophilus SEBioticReduced Pathogen-Induced Weight LossBeneficial
Large
Streptococcus thermophilus SL-21Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus SL-21Reduced Pathogen GrowthBeneficial
Large
Streptococcus thermophilus SL-21Stable Body WeightBeneficial
Moderate
Streptococcus thermophilus SP4Improved Biochemical ParametersBeneficial
Large
Streptococcus thermophilus SP4Reduced LPS-Induced Cellular ActivityBeneficial
Moderate
Streptococcus thermophilus SP4Reduced Pathogen ActivityBeneficial
Large
Streptococcus thermophilus SP4Reduced Significant Weight LossBeneficial
Large
Streptococcus thermophilus ST-21Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus ST-21Reduced Pathogen GrowthBeneficial
Large
Streptococcus thermophilus ST-21Reduced Pathogen-Induced Weight LossBeneficial
Large
Streptococcus thermophilus ST1447Inhibited Weight Loss in MiceBeneficial
Large
Streptococcus thermophilus ST1447Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus ST1447Reduced Cytotoxic EffectsBeneficial
Moderate
Streptococcus thermophilus ST1447Reduced Pathogen ActivityBeneficial
Large
Streptococcus thermophilus TH-4Enhanced Gastrointestinal SurvivalBeneficial
Large
Streptococcus thermophilus TH-4Improved Biochemical ParametersBeneficial
Large
Streptococcus thermophilus TH-4Maintained WeightBeneficial
Large
Streptococcus thermophilus TH-4Reduced InflammationBeneficial
Large
Streptococcus thermophilus TH-4Reduced Pathogen ActivityBeneficial
Large
Streptococcus thermophilus UASt-09Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus UASt-09Prevented Significant Weight LossBeneficial
Large
Streptococcus thermophilus UASt-09Reduced Inflammation in RAW264.7 CellsBeneficial
Large
Streptococcus thermophilus UASt-09Reduced Pathogen ActivityBeneficial
Large
Streptococcus thermophilus VPro 23Enhanced Antimicrobial ActivityBeneficial
Large
Streptococcus thermophilus VPro 23Improved Biochemical ParametersBeneficial
Large
Streptococcus thermophilus VPro 23Prevented Significant Weight LossBeneficial
Large
Streptococcus thermophilus VPro 23Reduced Foodborne PathogensBeneficial
Large
Streptococcus thermophilus VPro 23Reduced Inflammation in RAW264.7 CellsBeneficial
Large
Streptococcus thermophilus Y08Normalization of Blood Biochemical ParametersBeneficial
Large
Streptococcus thermophilus Y08Reduced LPS-Induced Cellular ActivityBeneficial
Moderate
Streptococcus thermophilus Y08Reduced Pathogen ActivityBeneficial
Large
Back to top